Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil and caffeine in transfersomes improve hair growth treatment.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

A rare adrenal tumor in a 14-year-old girl caused male-like symptoms and was successfully removed.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Finasteride doesn't affect bone density in male rats.

Low prolactin in young women may increase heart and metabolism risks.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

The normal human prostate does not significantly affect blood DHT levels.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

Hormonal imbalances, often indicating conditions like PCOS, are common in women with hard-to-treat acne, and a treatment approach addressing these imbalances may be needed.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Sex neurosteroids cause different effects on hippocampal synaptic plasticity in males and females.

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

Measuring certain hormones can help predict metabolic risk in women with PCOS.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Blood hormone levels don't accurately show brain hormone levels in males.

Testosterone can slow hair growth in adult monkeys, but a blocker called RU 58841 can counteract this and potentially help hair regrow.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Higher androgen levels do not cause baldness in men.